Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mitochondrial disturbances in HIV pregnancies.
Morén C, Noguera-Julián A, Garrabou G, Rovira N, Catalán M, Bañó M, Guitart-Mampel M, Tobías E, Hernández S, Cardellach F, Miró Ò, Fortuny C. Morén C, et al. Among authors: hernandez s. AIDS. 2015 Jan 2;29(1):5-12. doi: 10.1097/QAD.0000000000000486. AIDS. 2015. PMID: 25268887
Mitochondrial toxicity and caspase activation in HIV pregnant women.
Hernandez S, Moren C, Catalán-García M, Lopez M, Guitart-Mampel M, Coll O, Garcia L, Milisenda J, Justamante A, Gatell JM, Cardellach F, Gratacos E, Miro Ò, Garrabou G. Hernandez S, et al. J Cell Mol Med. 2017 Jan;21(1):26-34. doi: 10.1111/jcmm.12935. Epub 2016 Aug 30. J Cell Mol Med. 2017. PMID: 27577111 Free PMC article.
Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis, and Adverse Perinatal Outcomes in HIV Pregnancies Under Antiretroviral Treatment Containing Zidovudine.
Hernández S, Catalán-García M, Morén C, García-Otero L, López M, Guitart-Mampel M, Milisenda J, Coll O, Cardellach F, Gratacós E, Miró Ò, Garrabou G. Hernández S, et al. J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):e113-e119. doi: 10.1097/QAI.0000000000001334. J Acquir Immune Defic Syndr. 2017. PMID: 28234688
Pharmacokinetic study of saquinavir 500 mg plus ritonavir (1000/100 mg twice a day) in HIV-positive pregnant women.
Martinez-Rebollar M, Lonca M, Perez I, Soy D, Brunet M, Martin R, Coll O, Hernandez S, Laguno M, Milinkovic A, Larrousse M, Calvo M, Blanco JL, Martínez E, Gatell JM, Mallolas J. Martinez-Rebollar M, et al. Among authors: hernandez s. Ther Drug Monit. 2011 Dec;33(6):772-7. doi: 10.1097/FTD.0b013e318236376d. Ther Drug Monit. 2011. PMID: 22105596
1,353 results